{"title":"用于炎性肠病的电化学生物传感器。","authors":"Mukhabbat Saidova , Nargiza Xamrakulova , Nodira Mirzayeva , Ilnur Аbitov , Firuza Turayeva , Barno Shagazatova , Gulchekhra Bekenova , Maxmudjon Butaboyev , Islom Kadirov , Bunyod Kendjaev , Bakhtiyor Khasanov , Nigora Dustova , Kurbaniyazova Madina Zafajanovna","doi":"10.1016/j.cca.2025.120651","DOIUrl":null,"url":null,"abstract":"<div><div>Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic and increasingly prevalent condition characterized by gastrointestinal inflammation and a substantial clinical burden. While conventional diagnostic modalities such as endoscopy and histopathology remain essential, their invasiveness and limited suitability for continuous monitoring underscore the need for innovative, patient-friendly approaches. Electrochemical biosensors have emerged as transformative tools for noninvasive and minimally invasive IBD detection, offering rapid, sensitive, and matrix-flexible analysis of key biomarkers in blood, sweat, stool, and urine. This review presents a comprehensive overview of recent advancements in electrochemical biosensor technology for the noninvasive detection of IBD. It explores cutting-edge developments in biorecognition elements, transducer configurations, signal amplification techniques, and detection modalities. These innovations collectively demonstrate the transformative potential of electrochemical biosensors to reshape IBD diagnostics, enabling personalized, real-time monitoring and paving the way for more accessible, patient-centered disease management.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"579 ","pages":"Article 120651"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electrochemical biosensors for inflammatory bowel disease\",\"authors\":\"Mukhabbat Saidova , Nargiza Xamrakulova , Nodira Mirzayeva , Ilnur Аbitov , Firuza Turayeva , Barno Shagazatova , Gulchekhra Bekenova , Maxmudjon Butaboyev , Islom Kadirov , Bunyod Kendjaev , Bakhtiyor Khasanov , Nigora Dustova , Kurbaniyazova Madina Zafajanovna\",\"doi\":\"10.1016/j.cca.2025.120651\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic and increasingly prevalent condition characterized by gastrointestinal inflammation and a substantial clinical burden. While conventional diagnostic modalities such as endoscopy and histopathology remain essential, their invasiveness and limited suitability for continuous monitoring underscore the need for innovative, patient-friendly approaches. Electrochemical biosensors have emerged as transformative tools for noninvasive and minimally invasive IBD detection, offering rapid, sensitive, and matrix-flexible analysis of key biomarkers in blood, sweat, stool, and urine. This review presents a comprehensive overview of recent advancements in electrochemical biosensor technology for the noninvasive detection of IBD. It explores cutting-edge developments in biorecognition elements, transducer configurations, signal amplification techniques, and detection modalities. These innovations collectively demonstrate the transformative potential of electrochemical biosensors to reshape IBD diagnostics, enabling personalized, real-time monitoring and paving the way for more accessible, patient-centered disease management.</div></div>\",\"PeriodicalId\":10205,\"journal\":{\"name\":\"Clinica Chimica Acta\",\"volume\":\"579 \",\"pages\":\"Article 120651\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica Chimica Acta\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009898125005303\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125005303","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Electrochemical biosensors for inflammatory bowel disease
Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic and increasingly prevalent condition characterized by gastrointestinal inflammation and a substantial clinical burden. While conventional diagnostic modalities such as endoscopy and histopathology remain essential, their invasiveness and limited suitability for continuous monitoring underscore the need for innovative, patient-friendly approaches. Electrochemical biosensors have emerged as transformative tools for noninvasive and minimally invasive IBD detection, offering rapid, sensitive, and matrix-flexible analysis of key biomarkers in blood, sweat, stool, and urine. This review presents a comprehensive overview of recent advancements in electrochemical biosensor technology for the noninvasive detection of IBD. It explores cutting-edge developments in biorecognition elements, transducer configurations, signal amplification techniques, and detection modalities. These innovations collectively demonstrate the transformative potential of electrochemical biosensors to reshape IBD diagnostics, enabling personalized, real-time monitoring and paving the way for more accessible, patient-centered disease management.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.